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ABSTRACT 
Kaempferia galanga has anti-inflammatory activity and worth developing as lipoxygenase inhibitors. The aim of this study 
was to determined δ-3-carene, one of the potential compounds of K. galanga, as a lipoxygenase inhibitor. The LOX-inhibitor 
activity was tested in-vitro. The result showed that the IC50 of δ-3-carene was 23.10 µM, which was less potential compare to 
zileuton (7.54 µM). The study showed that K. galanga contains possible active components that could be developed as 5-LOX-
inhibitor. 
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1. INTRODUCTION 
Kaempferia galanga rhizome has been known for its 
various activities, such as anti-inflammatory[1]. The main 
components are ethyl p-methoxycinamic (30%), ethyl 
cinnamate (25%), p-methoxycinamic acid, monoterpenes 
ketone, and 3-carene-5-one [2]. It has shown potential in 
inhibiting cyclooxygenase (COX) and perhaps also binds to 
the lipoxygenase (LOX) enzyme. In previous study, the 
docking and molecular dynamics stimulation study showed 
that, among the compounds of K. galanga, the highest 
affinity towards 5 –LOX was shown by δ-3-carene. 
Therefore, in this study, we further examined the activity of 




The Lipoxygenase (LOX) inhibitor Screening assay kit 
(Abnova, Taiwan) was used in this study. Zileuton (sigma, 
US) used as comparator. Lipoxygenase enzyme was used as 
a standard and linoleic acid as the substrate. The kit detects 
and measures the hydroperoxides produced in the 
lipoxygenase reaction. The zileuton and δ-3-carene (Sigma, 
US) were dissolve in ethanol. The procedure was done 
based on the kit instruction. The result was read at 490 nm. 
 
3. RESULT AND DISCUSSION 
K. galanga has been studied as anti-inflammatory [3– 
8]. Despite many studies of the rhizome on inflammation, 
there has not been research of the compounds of K. galanga 
as lipoxygenase inhibitor. Lipoxygenase (LOX) plays a role 
in the metabolic process of arachidonic acid (AA) that could 
produce leukotriene (LT), which mediates inflammation. 
LOX inhibition can reduce LT, resulting in anti-
inflammatory effects [9]. Inflammatory mediators produced 
by cyclooxygenase (COX) and lipoxygenase (LOX) 
pathways are responsible for many diseases in humans, such 
as cancer, arthritis, autoimmune, cardiovascular, and 
neurological disorders. Studies showed mediators produced 
by 5-LOX, 12-LOX, and 15-LOX associated with allergic 
reactions, and the pathogenesis of atherosclerosis [10]. The 
research was started by in-silico study of 21 potential 
compounds of K. galanga, : ethyl cinnamate, ethyl p-
methoxycinamic acid, p-methoxycinamic acid, 3-carene-5-
one, camphene, δ-3- carene, p-methoxy styrene, γ-pinene , 
β-myrcene, p- cymene, 1,8-cineole, iso-myrcene, camphor, 
α-terpineol, p-cymene- 8-ol, eucarvone, δ-cadinene, 
kaempferol, quercetin, cyanidin and delphinidin. The 
highest affinity towards LOX was shown by δ-3-carene, 
then this compound was continued to be tested in in-vitro 
study. The result of the study showed that the IC50 of δ-3- 
carene was 23.10 µM, which was less potential compare to 
zileuton (7.54 µM) (Figure 1 and 2). This result indicated 
that carene has the activity towards 5-LOX. Therefore, 
further study is crucial to confirm the 5-LOX inhibitor 
activity of δ-3-carene and other compounds of 
K. galanga. 
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Figure 2. δ-3-carene Lipoxygenase Inhibition 
4. CONCLUSION 
Kaempferia galanga has anti-inflammatory activity and 
worth developing as lipoxygenase inhibitors. The aim of 
this study was to determined δ-3-carene, one of the potential 
compounds of K. galanga, as a lipoxygenase inhibitor. The 
LOX-inhibitor activity was tested in-vitro. The result 
showed that the IC50 of δ-3-carene was 23.10 µM, which 
was less potential compare to zileuton (7.54 µM). The study 
showed that K. galanga contains possible active 
components that could be developed as 5-LOX-inhibitor. 
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